Gemtuzumab Ozogamicin a Safe, Tolerable Option for Patients With Relapsed/Refractory AML by HMP Global

Early Results Show Promise With Venetoclax-Idasanutlin Combo for Relapsed/Refractory AML by HMP Global

Extended Decitabine Dosing Schedule Provides No Benefit Over Shorter Regimen in Newly Diagnosed AML by HMP Global

The Use of CAR-T Therapy for B-Cell Lymphomas Outside of Clinical Trials by HMP Global

Round 1: The Use of Adjuvant And Neoadjuvant Chemotherapy in Soft-Tissue Sarcoma by HMP Global

Introduction: The Use of Adjuvant/ Neoadjuvant Chemotherapy in Soft-Tissue Sarcoma by HMP Global

Quadruplet Therapy Yields Promising Results in Newly Diagnosed MM by HMP Global

Penn Medicine Looks to Improve Outcomes For Solid Tumors With CAR-T by HMP Global

Navigating the Treatment Landscape for Multiple Myeloma - Callander by HMP Global

Cost of Cancer Care in the Outpatient vs Community Oncology Setting - Lucio Gordon by HMP Global